HC Wainwright initiated coverage on shares of TuHURA Biosciences (NASDAQ:HURA – Free Report) in a research report report published on Monday morning, MarketBeat reports. The firm issued a buy rating ...
Stock analysts at HC Wainwright issued their Q2 2025 earnings estimates for shares of TuHURA Biosciences in a research report issued to clients and investors on Monday, March 3rd. HC Wainwright ...